TRAW

Traws Pharma, Inc. - Common Stock (TRAW)

About Traws Pharma, Inc. - Common Stock (TRAW)

Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.

Details

Daily high

$2.09

Daily low

$1.95

Price at open

$1.99

52 Week High

$19.44

52 Week Low

$1.52

Market cap

10.0M

Dividend yield

0.00%

Volume

17,604

Avg. volume

42,997

P/E ratio

-.02

Traws Pharma, Inc. - Common Stock News